Fig. 5From: CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cellsa cell viability analysis of miR-1284 and Mutant miR on the HeLa cancer cells in a dose-dependent manner; b cell viability analysis of free CDDP and formulations on the viability of cancer cells. The cell viability was determined by MTT assay. ***p < 0.0001, CD/LP-miCDDP and vs free CDDPBack to article page